Αρχειοθήκη ιστολογίου

Παρασκευή 8 Σεπτεμβρίου 2017

(S)-crizotinib induces apoptosis in human non-small cell lung cancer cells by activating ROS independent of MTH1

Non–small cell lung cancer (NSCLC) accounts for approximately 80–85% of all lung cancers and is usually diagnosed at an advanced stage with poor prognosis. Targeted therapy has produced unprecedented outcomes ...

from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2j8W42Y

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου